Skip to content

Drug interactions

Darunavir + Deflazacort

Severity: Major

Darunavir and Deflazacort: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darunavir, usually boosted with ritonavir or cobicistat, strongly inhibits CYP3A4 and increases exposure to deflazacort's active metabolite. The risk of corticosteroid toxicity, including adrenal suppression and Cushing syndrome, is increased.

What this interaction means in plain words

Darunavir and Deflazacort can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Darunavir belongs to Anti Virals; Deflazacort belongs to Miscellaneous.

Evidence level: High

Why it happens

Darunavir and its booster inhibit CYP3A4, reducing clearance of deflazacort's active metabolite.

What to do

Reduce the deflazacort dose to one-third of the usual dose and monitor for steroid adverse effects, or choose an alternative corticosteroid-sparing approach.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darunavir and Deflazacort, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darunavir with Deflazacort?

MediHelp rates the interaction as major. Darunavir and Deflazacort can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Darunavir, usually boosted with ritonavir or cobicistat, strongly inhibits CYP3A4 and increases exposure to deflazacort's active metabolite. The risk of corticosteroid toxicity, including adrenal suppression and Cushing syndrome, is increased.

How serious is the interaction between Darunavir and Deflazacort?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the deflazacort dose to one-third of the usual dose and monitor for steroid adverse effects, or choose an alternative corticosteroid-sparing approach.

What other medicines interact with Deflazacort?

MediHelp also lists interactions of Deflazacort with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Deflazacort page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in